Back
AbbVie, Inc. Vs. Amgen, Inc. Industry Stock Comparison
Sell
50
ABBV
AbbVie, Inc.
Last Price:
$219.13
Seasonality Move:
2.16%
Sell
41
AMGN
Amgen, Inc.
Last Price:
$319.33
Seasonality Move:
5.99%
Sell
50
AbbVie, Inc. (ABBV)
is a Sell
Is AbbVie, Inc. a Buy, Sell or Hold?
-
The current AbbVie, Inc. [ABBV] share price is $229.31. The Score for ABBV is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
ABBV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Amgen, Inc. (AMGN)
is a Sell
Is Amgen, Inc. a Buy, Sell or Hold?
-
The current Amgen, Inc. [AMGN] share price is $327.64. The Score for AMGN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
AMGN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ABBV Stock Price Chart
What is AbbVie, Inc.'s stock price today?
-
The AbbVie, Inc. share price today is $229.31Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABBV is experiencing slight buying pressure.
AMGN Stock Price Chart
What is Amgen, Inc.'s stock price today?
-
The Amgen, Inc. share price today is $327.64Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMGN is experiencing slight buying pressure.
ABBV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.78 | Buy |
| Relative Strength Index (14 RSI): | 53.89 | Buy |
| Chaikin Money Flow: | 1439571 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (224.15 - 229.33) | Buy |
| Bollinger Bands (100): | (213.73 - 231.91) | Buy |
AMGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.01 | Buy |
| Relative Strength Index (14 RSI): | 50.16 | Buy |
| Chaikin Money Flow: | 397825 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (320.86 - 338.32) | Sell |
| Bollinger Bands (100): | (283.33 - 328.11) | Buy |
ABBV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 229.37 | Sell |
| 20-day SMA: | 226.67 | Buy |
| 50-day SMA: | 226.66 | Buy |
| 200-day SMA: | 206.14 | Buy |
| 8-day EMA: | 228.82 | Buy |
| 20-day EMA: | 227.79 | Buy |
| 50-day EMA: | 226.16 | Buy |
| 200-day EMA: | 210.81 | Buy |
AMGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 330.38 | Sell |
| 20-day SMA: | 326.43 | Buy |
| 50-day SMA: | 323.66 | Buy |
| 200-day SMA: | 297.76 | Buy |
| 8-day EMA: | 328.77 | Sell |
| 20-day EMA: | 328.4 | Sell |
| 50-day EMA: | 322.3 | Buy |
| 200-day EMA: | 304.32 | Buy |
AbbVie, Inc. Earnings Growth & ABBV Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.61 per share, and an increase next year of $1.59 per share.
Amgen, Inc. Earnings Growth & AMGN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and an increase next year of $0.69 per share.
AbbVie, Inc. Technical Analysis
| Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amgen, Inc. Technical Analysis
| Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | Jan 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||